Showing results (391-400 of 409) with videos related to
Sort By:
Pageof 41
Journal of Neuroscience Methods|August 4, 2010
Assessing the reliability to detect cerebral hypometabolism in probable Alzheimer's disease and amnestic mild cognitive impairmentXia Wu, Kewei Chen, Li Yao, et al.Neuroimage|October 5, 2010
Association between GAB2 haplotype and higher glucose metabolism in Alzheimer's disease-affected brain regions in cognitively normal APOEε4 carriersWinnie S Liang, Kewei Chen, Wendy Lee, et al.The Science of the Total Environment|September 26, 2025
Prenatal exposure to dietary levels of glyphosate disrupts metabolic, immune, and behavioral markers across generations in miceJ A Barnett, J K Josephson, E Yuzbashian, et al.Contemporary Clinical Trials|January 10, 2019
STRONG-D: Strength training regimen for normal weight diabetics: Rationale and designLida Faroqi, Saniya Bonde, Daniella Tatianna Goni, et al.Critical Care Explorations|September 3, 2021
Risk Factors for Critical Coronavirus Disease 2019 and Mortality in Hospitalized Young Adults: An Analysis of the Society of Critical Care Medicine Discovery Viral Infection and Respiratory Illness Universal Study (VIRUS) Coronavirus Disease 2019 RegistrySandeep Tripathi, Imran A Sayed, Heda Dapul, et al.MMWR. Morbidity and Mortality Weekly Report|October 8, 2020
Adolescent with COVID-19 as the Source of an Outbreak at a 3-Week Family Gathering - Four States, June-July 2020Noah G Schwartz, Anne C Moorman, Anna Makaretz, et al.Neuroimage|February 1, 2011
Characterizing Alzheimer's disease using a hypometabolic convergence indexKewei Chen, Napatkamon Ayutyanont, Jessica B S Langbaum, et al.The Journal of Infectious Diseases|September 24, 2008
Community outbreak of Mycoplasma pneumoniae infection: school-based cluster of neurologic disease associated with household transmission of respiratory illnessNicholas D Walter, Gavin B Grant, Utpala Bandy, et al.Journal of Alzheimer'S Disease : JAD|October 9, 2010
A multi-center randomized proof-of-concept clinical trial applying [¹⁸F]FDG-PET for evaluation of metabolic therapy with rosiglitazone XR in mild to moderate Alzheimer's diseaseSofia Tzimopoulou, Vincent J Cunningham, Thomas E Nichols, et al.Emerging Infectious Diseases|June 8, 2007
Pet rodents and fatal lymphocytic choriomeningitis in transplant patientsBrian R Amman, Boris I Pavlin, Cesar G Albariño, et al.Pageof 41